Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas

Part of paid clinical trials in Anniston, Alabama.

Sponsor
Alliance for Clinical Trials in Oncology
Study ID
NCT00012220
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • cisplatin — DRUG
    50 mg/sq m IV infusion over 30 min on Days 1 \& 15 of ea cycle
  • docetaxel — DRUG
    40 mg/sq m IV infusion over 60 min on Days 1 \& 8 of ea treatment cycle
  • gemcitabine hydrochloride — DRUG
    Gemcitabine only arm: 1500 mg/sq m in 250 mL NS IV infusion over 150 min Days 1, 8, \& 15 of ea cycle * cisplastin arm: 1000 mg/sq m 250 mL NS IV infusion over 30 min Days 1, 8, 15 of ea cycle * docetaxel and + irinotecan arms: 1000 mg/sq m in 250 mL NS IV infusion over 30 min Days 1 \& 8 of ea cycle
  • irinotecan hydrochloride — DRUG
    100 mg/q m in 500 mL D5W or D5NS IV infusion over 90 min Days 1 \& 8 of ea cycle

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if gemcitabine is more effective when given alone or in combination with another chemotherapy drug in treating cancer of the pancreas. PURPOSE: Randomized phase II trial to compare the effectiveness of gemcitabine given alone or in combination with other chemotherapy drugs in treating patients who have metastatic cancer of the pancreas.

Key Dates

Start date
Jan 31, 2001
Status verified
Jul 2016
Primary completion
Jun 30, 2004
Completion
Apr 30, 2009

Study Design

Enrollment
259 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Gemcitabine
    Standard treatment
  • Experimental: Gemcitabine + cisplastin
    Addition of cisplastin to gemcitabine
  • Experimental: Gemcitabine + docetaxel
    Addition of docetaxel to gemcitabine
  • Experimental: Gemcitabine + Irinotecan
    Addition of irinotecan to gemcitabine

Primary Outcome Measure

Overall Survival [ Time Frame: 4 years post treatment ]

Locations (75)

FacilityCityStateZIPSite coordinators
Northeast Alabama Regional Medical CenterAnnistonAlabama36207-
Rebecca and John Moores UCSD Cancer CenterLa JollaCalifornia92093-0658-
Veterans Affairs Medical Center - San DiegoSan DiegoCalifornia92161-
UCSF Comprehensive Cancer CenterSan FranciscoCalifornia94115-
Veterans Affairs Medical Center - San FranciscoSan FranciscoCalifornia94121-
CCOP - Christiana Care Health ServicesNewarkDelaware19713-
Lombardi Cancer CenterWashington D.C.District of Columbia20007-
Veterans Affairs Medical Center - Washington, DCWashington D.C.District of Columbia20422-
Walter Reed Army Medical CenterWashington D.C.District of Columbia20307-5000-
Broward General Medical CenterFort LauderdaleFlorida33316-
Memorial Regional Hospital Comprehensive Cancer CenterHollywoodFlorida33021-
CCOP - Mount Sinai Medical CenterMiami BeachFlorida33140-
Florida Hospital Cancer InstituteOrlandoFlorida32804-
Helen and Harry Gray Cancer Institute at Good Samaritan Medical CenterWest Palm BeachFlorida33401-
Louis A. Weiss Memorial HospitalChicagoIllinois60640-
University of Chicago Cancer Research CenterChicagoIllinois60637-1470-
Veterans Affairs Medical Center - Chicago (Westside Hospital)ChicagoIllinois60612-
West Suburban Center for Cancer CareRiver ForestIllinois60305-
Saint Anthony Medical CenterRockfordIllinois61108-
Fort Wayne Medical Oncology and Hematology, IncorporatedFort WayneIndiana46885-5099-
CCOP - Northern Indiana CR ConsortiumSouth BendIndiana46601-
Hematology Oncology Associates of the Quad CitiesBettendorfIowa52722-
Holden Comprehensive Cancer Center at University of IowaIowa CityIowa52242-1009-
Baptist Hospital East - LouisvilleLouisvilleKentucky40207-
Marlene and Stewart Greenebaum Cancer Center, University of MarylandBaltimoreMaryland21201-
Veterans Affairs Medical Center - BaltimoreBaltimoreMaryland21201-
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer InstituteBostonMassachusetts02115-
University of Massachusetts Memorial Medical Center - University CampusWorcesterMassachusetts01655-
Lakeland Medical Center - St. JosephSaint JosephMichigan49085-
University of Minnesota Cancer CenterMinneapolisMinnesota55455-
Veterans Affairs Medical Center - MinneapolisMinneapolisMinnesota55417-
Ellis Fischel Cancer Center at University of Missouri - ColumbiaColumbiaMissouri65203-
Veterans Affairs Medical Center - Columbia (Truman Memorial)ColumbiaMissouri65201-
Barnes-Jewish HospitalSt LouisMissouri63110-
University of Nebraska Medical CenterOmahaNebraska68198-7680-
CCOP - Southern Nevada Cancer Research FoundationLas VegasNevada89106-
Veterans Affairs Medical Center - Las VegasLas VegasNevada89106-
Norris Cotton Cancer CenterLebanonNew Hampshire03756-0002-
Cooper University HospitalCamdenNew Jersey08103-
Roswell Park Cancer InstituteBuffaloNew York14263-0001-
Veterans Affairs Medical Center - BuffaloBuffaloNew York14215-
Elmhurst Hospital CenterElmhurstNew York11373-
Queens Cancer Center of Queens HospitalJamaicaNew York11432-
CCOP - North Shore University HospitalManhassetNew York11030-
North Shore University HospitalManhassetNew York11030-
Memorial Sloan-Kettering Cancer CenterNew YorkNew York10021-
Mount Sinai Medical Center, NYNew YorkNew York10029-
New York Weill Cornell Cancer Center at Cornell UniversityNew YorkNew York10021-
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.SyracuseNew York13217-
State University of New York - Upstate Medical UniversitySyracuseNew York13210-
Veterans Affairs Medical Center - SyracuseSyracuseNew York13210-
Veterans Affairs Medical Center - AshevilleAshevilleNorth Carolina28805-
Lineberger Comprehensive Cancer Center, UNCChapel HillNorth Carolina27599-7295-
NorthEast Oncology AssociatesConcordNorth Carolina28025-
Duke Comprehensive Cancer CenterDurhamNorth Carolina27710-
Veterans Affairs Medical Center - DurhamDurhamNorth Carolina27705-
Cape Fear Valley Health SystemFayettevilleNorth Carolina28302-2000-
Lenoir Memorial Hospital Cancer CenterKinstonNorth Carolina28503-1678-
FirstHealth Moore Regional HospitalPinehurstNorth Carolina28374-
New Hanover Regional Medical CenterWilmingtonNorth Carolina28402-9025-
CCOP - Southeast Cancer Control ConsortiumWinston-SalemNorth Carolina27104-4241-
Comprehensive Cancer Center at Wake Forest UniversityWinston-SalemNorth Carolina27157-1082-
Veterans Affairs Medical Center - FargoFargoNorth Dakota58102-
Arthur G. James Cancer Hospital - Ohio State UniversityColumbusOhio43210-1240-
Lifespan: The Miriam HospitalProvidenceRhode Island02906-
Veterans Affairs Medical Center - DallasDallasTexas75216-
Green Mountain Oncology GroupBenningtonVermont05201-
Vermont Cancer Center at University of VermontBurlingtonVermont05401-3498-
Veterans Affairs Medical Center - White River JunctionWhite River JunctionVermont05009-
Martha Jefferson HospitalCharlottesvilleVirginia22902-
Virginia Oncology Associates - NorfolkNorfolkVirginia23502-
MBCCOP - Massey Cancer CenterRichmondVirginia23298-0037-
Oncology and Hematology Associates of Southwest Virginia, Inc.RoanokeVirginia24014-
St. Mary's Medical CenterHuntingtonWest Virginia25701-
Ministry Medical Group - Northern RegionRhinelanderWisconsin54501-

Find similar trials in Anniston, AL

By condition

Related Studies